Lyka Labs may keep rerating if the subsidiary sale sharpens margins and cash flow.
This is a cleaner turnaround story than many of the day’s other earnings updates because it combines profit growth with portfolio pruning. Investors will watch whether the restructuring improves margins beyond one quarter.
AI reasoning
This is a cleaner turnaround story than many of the day’s other earnings updates because it combines profit growth with portfolio pruning. Investors will watch whether the restructuring improves margins beyond one quarter.
Curated summary
Lyka Labs reported Q1 FY27 standalone revenue of Rs 42.31 crore, up 45.7 percent year on year, with net profit rising to Rs 2.10 crore from Rs 0.81 crore a year earlier. Profit before tax rose 71 percent to Rs 1.99 crore. The company also approved selling its 100 percent stake in Lyka BDR International, a subsidiary that contributed 8 percent of consolidated income in FY26 but had negative net worth.
Supporting evidence
Source news
Lyka Labs posts a sharp Q1 rebound and moves to sell a loss-making subsidiary
Revenue rose 46 percent and profit jumped 159 percent, while the company approved a full stake sale in Lyka BDR International.
